GYRE

NASDAQ · Biotechnology

Gyre Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.67

+0.27 (+4.22%)

As of Aug 8, 10:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +348.6% upside

Low Target $20.05

Average Target $29.92

High Target $33.42

Current Price $6.67

Current
$6.67

Target
$29.92

$20.05 $29.92 avg $33.42

Scenario Analysis

Bear Case

$20.05

200.6%

Low target

Base Case

$29.92

+348.6%

Avg target

Bull Case

$33.42

+401.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$9.42

-29.2% from high

52-Week Low

$5.44

+22.6% from low

Target vs 52W High

$29.92

+217.6% vs high

Next Earnings Report

Aug 18, 2026

until earnings

EPS Est: $-0.09

Earnings in 8 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%